| Ingrid Flores-freeth, MD | |
|
3049 36th Street, Astoria, NY 11103 | |
| (718) 278-2126 | |
| (718) 545-8894 |
| Full Name | Ingrid Flores-freeth |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 3049 36th Street, Astoria, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609832211 | NPI | - | NPPES |
| 02195733 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 221212 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tjh Medical Services Pc | 8527960533 | 194 |
News Archive
Myriad Genetics, Inc. today announced the launch of PANEXIA™, a predictive medicine product for hereditary pancreatic and related cancers. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. PANEXIA, Myriad's ninth molecular diagnostic product, is the second product launched by the Company this year.
To receive the 2011 CCHIT Comprehensive certification, the Pulse EHR had to undergo a rigorous inspection of integrated functionality, interoperability and security, in addition to achieving full compliance with proposed federal standards tied to ARRA "meaningful use" financial incentives.
The Institute of Medicine estimates that up to 30% of care provided in the United States is unnecessary and provides little value to patients given the cost and available alternatives.
People who undergo repeated surgeries to remove glioblastomas - the most aggressive and deadliest type of brain tumors - may survive longer than those who have just a one-time operation, new Johns Hopkins research suggests.
Global HIV leaders have committed to ensuring young people affected by HIV/AIDS play an integral part in shaping new research and policies to strengthen HIV prevention, testing and treatment in sub-Saharan Africa.
› Verified 1 days ago
| Entity Name | Tjh Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184670465 PECOS PAC ID: 8527960533 Enrollment ID: O20040121000802 |
News Archive
Myriad Genetics, Inc. today announced the launch of PANEXIA™, a predictive medicine product for hereditary pancreatic and related cancers. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. PANEXIA, Myriad's ninth molecular diagnostic product, is the second product launched by the Company this year.
To receive the 2011 CCHIT Comprehensive certification, the Pulse EHR had to undergo a rigorous inspection of integrated functionality, interoperability and security, in addition to achieving full compliance with proposed federal standards tied to ARRA "meaningful use" financial incentives.
The Institute of Medicine estimates that up to 30% of care provided in the United States is unnecessary and provides little value to patients given the cost and available alternatives.
People who undergo repeated surgeries to remove glioblastomas - the most aggressive and deadliest type of brain tumors - may survive longer than those who have just a one-time operation, new Johns Hopkins research suggests.
Global HIV leaders have committed to ensuring young people affected by HIV/AIDS play an integral part in shaping new research and policies to strengthen HIV prevention, testing and treatment in sub-Saharan Africa.
› Verified 1 days ago
| Entity Name | Flushing Hospital & Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548217763 PECOS PAC ID: 2668367483 Enrollment ID: O20040219000415 |
News Archive
Myriad Genetics, Inc. today announced the launch of PANEXIA™, a predictive medicine product for hereditary pancreatic and related cancers. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. PANEXIA, Myriad's ninth molecular diagnostic product, is the second product launched by the Company this year.
To receive the 2011 CCHIT Comprehensive certification, the Pulse EHR had to undergo a rigorous inspection of integrated functionality, interoperability and security, in addition to achieving full compliance with proposed federal standards tied to ARRA "meaningful use" financial incentives.
The Institute of Medicine estimates that up to 30% of care provided in the United States is unnecessary and provides little value to patients given the cost and available alternatives.
People who undergo repeated surgeries to remove glioblastomas - the most aggressive and deadliest type of brain tumors - may survive longer than those who have just a one-time operation, new Johns Hopkins research suggests.
Global HIV leaders have committed to ensuring young people affected by HIV/AIDS play an integral part in shaping new research and policies to strengthen HIV prevention, testing and treatment in sub-Saharan Africa.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ingrid Flores-freeth, MD 8906 135th Street, 7l, Jamaica, NY 11418 Ph: (718) 206-6984 | Ingrid Flores-freeth, MD 3049 36th Street, Astoria, NY 11103 Ph: (718) 278-2126 |
News Archive
Myriad Genetics, Inc. today announced the launch of PANEXIA™, a predictive medicine product for hereditary pancreatic and related cancers. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. PANEXIA, Myriad's ninth molecular diagnostic product, is the second product launched by the Company this year.
To receive the 2011 CCHIT Comprehensive certification, the Pulse EHR had to undergo a rigorous inspection of integrated functionality, interoperability and security, in addition to achieving full compliance with proposed federal standards tied to ARRA "meaningful use" financial incentives.
The Institute of Medicine estimates that up to 30% of care provided in the United States is unnecessary and provides little value to patients given the cost and available alternatives.
People who undergo repeated surgeries to remove glioblastomas - the most aggressive and deadliest type of brain tumors - may survive longer than those who have just a one-time operation, new Johns Hopkins research suggests.
Global HIV leaders have committed to ensuring young people affected by HIV/AIDS play an integral part in shaping new research and policies to strengthen HIV prevention, testing and treatment in sub-Saharan Africa.
› Verified 1 days ago
Dr. John Joseph Pellettieri, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3049 36th Street, Astoria, NY 11103 Phone: 718-278-2126 Fax: 718-545-8894 | |
Naida Dzanic Cemalovic, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3016 30th Dr, Fifth Floor, Astoria, NY 11102 Phone: 718-545-0003 Fax: 718-545-0317 | |
Gary David Steinman, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4601 Broadway, Astoria, NY 11103 Phone: 718-278-7676 Fax: 718-278-0354 | |
Dr. Michael Tonsor Ii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2818 Astoria Blvd, Astoria, NY 11102 Phone: 917-410-6905 | |
Dr. Marieme Mbaye, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2818 Astoria Blvd, Astoria, NY 11102 Phone: 917-410-6905 Fax: 646-878-6095 | |
Dr. Aruna Yedla, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2318 31st St, Astoria, NY 11105 Phone: 718-204-2200 Fax: 718-204-2218 | |
Kuhali Kundu, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2520 30th Ave Fl 4, Astoria, NY 11102 Phone: 718-808-7777 |